BIO-TECHNE Corp (TECH) FY2026 Annual Balance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
BIO-TECHNE Corp (TECH) FY2026 Annual Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$163.70 MCurrent assets$744.40 MLiabilities(calculated)$478.51 MAssets$2.59 BEquity$2.11 BNon-current liabilities$314.81 MNon-current assets$1.84 BGross equity(calculated)$2.18 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsAccounts receivable, less allowances of $4,644 and $4,215, respectivelyInventoriesOther current assetsGoodwillIntangible assets, netOther assetsProperty and equipment, netRight-of-use assetsSalaries, wages and related accrualsContract liabilitiesTrade accounts payableAccrued expensesOperating lease liabilities - currentOther current liabilitiesIncome taxes payableLong-term debt obligationsOperating lease liabilitiesOther long-term liabilitiesDeferred income taxesRetained earningsAdditional paid-in capitalCommon stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 156,095,113 and 154,972,196 respectivelyCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilities (calculated)EquityGross equity (calculated)Accumulated other comprehensive lossSalaries, wages and related accrualsSalaries, wages and related accruals$57.92 MContract liabilitiesContract liabilities$36.07 MTrade accounts payableTrade accounts payable$26.70 MCurrent liabilitiesCurrent liabilities$163.70 MAccrued expensesAccrued expenses$20.46 MCurrent assetsCurrent assets$744.40 MCash and cash equivalentsCash and cash equivalents$264.71 MOperating lease liabilities - currentOperating lease liabilities - current$14.94 MLiabilities (calculated)Liabilities(calculated)$478.51 MAccounts receivable, less allowances of $4,644 and $4,215, respectivelyAccounts receivable, net$216.59 MAssetsAssets$2.59 BOther current liabilitiesOther current liabilities$4.03 MInventoriesInventories$195.74 MIncome taxes payableIncome taxes payable$3.59 MOther current assetsOther current assets$67.36 MLong-term debt obligationsLong-term debt obligations$200.00 MEquityEquity$2.11 BNon-current liabilitiesNon-current liabilities$314.81 MNon-current assetsNon-current assets$1.84 BOperating lease liabilitiesOperating lease liabilities$74.15 MGoodwillGoodwill$975.36 MOther long-term liabilitiesOther long-term liabilities$21.35 MDeferred income taxesDeferred income taxes$19.31 MGross equity (calculated)Gross equity(calculated)$2.18 BIntangible assets, netIntangible assets, net$303.47 MOther assetsOther assets$264.34 MRetained earningsRetained earnings$1.14 BProperty and equipment, netProperty and equipment, net$231.84 MRight-of-use assetsRight-of-use assets$67.33 MAdditional paid-in capitalAdditional paid-in capital$1.03 BCommon stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 156,095,113 and 154,972,196 respectivelyCommon stock$1.56 MAccumulated other comprehensive lossAccumulated other comprehensive loss−$70.58 M
Chart details

BIO-TECHNE Corp (TECH) FY2026 Annual Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
2,586,726,000 US dollars
Current assets
744,401,000 US dollars
Non-current assets
1,842,325,000 US dollars
Liabilities (calculated)
478,505,000 US dollars
Current liabilities
163,700,000 US dollars
Non-current liabilities
314,805,000 US dollars
Equity
2,108,221,000 US dollars
Cash and cash equivalents
264,712,000 US dollars
Accounts receivable, less allowances of $4,644 and $4,215, respectively
216,585,000 US dollars
Inventories
195,744,000 US dollars
Other current assets
67,360,000 US dollars
Goodwill
975,355,000 US dollars
Intangible assets, net
303,465,000 US dollars
Other assets
264,336,000 US dollars
Property and equipment, net
231,836,000 US dollars
Right-of-use assets
67,333,000 US dollars
Salaries, wages and related accruals
57,918,000 US dollars
Contract liabilities
36,072,000 US dollars
Trade accounts payable
26,699,000 US dollars
Accrued expenses
20,458,000 US dollars
Operating lease liabilities - current
14,935,000 US dollars
Other current liabilities
4,025,000 US dollars
Income taxes payable
3,593,000 US dollars
Long-term debt obligations
200,000,000 US dollars
Operating lease liabilities
74,152,000 US dollars
Other long-term liabilities
21,345,000 US dollars
Deferred income taxes
19,308,000 US dollars
Retained earnings
1,144,188,000 US dollars
Additional paid-in capital
1,033,052,000 US dollars
Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 156,095,113 and 154,972,196 respectively
1,561,000 US dollars
Undesignated capital stock, par value $.01 per share; authorized 5,000,000 shares; none issued or outstanding
0 US dollars
Accumulated other comprehensive loss
negative 70,580,000 US dollars
Gross equity (calculated)
2,178,801,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
BIO-TECHNE Corp (TECH) FY2026 Annual Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!